Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 6 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 6

From: Role of [18F] FDG PET-CT in detection of COVID-19 vaccine-associated hypermetabolic lymphadenopathy (VAHL) in lymphoma patients: with serologic testing correlation

Fig. 6

A 39-year-old male patient with NHL, treated with anti-cd20 antibody rituximab 3 months prior to vaccination. FDG PET/CT performed 7 days after the 2nd dose of Pfizer-BioNTech COVID-19 vaccine. A Axial and C coronal CECT images at the axillary level revealed enlarged left axillary LNs about 3.5 cm B Axial and D coronal PET/CT images revealed FDG-avid left axillary LNs with 3.7 SUVmax uptake

Back to article page